Literature DB >> 30370213

To investigate the affiliation of XRCC-1 Gene Arg194Trp polymorphism in alcohol and tobacco substance users and loco-regionally progressed Laryngeal squamous cell carcinoma.

Raturi Vijay Parshuram1, Rajendra Kumar1, Madan Lal Brahma Bhatt1, Rahul Singh1, Devendra Parmar2, Jalaj Gaur1, Dewesh Kishan1, Mandira Saha1, Pranay Katepogu1, Prasad Senthamizh3, Tridiv Katiyar2.   

Abstract

OBJECTIVES: The correlation of XRCC-1 Gene Arg194Trp polymorphism with alcohol and tobacco substance user and with loco-regionally progressed squamous cell cancer of the larynx (LSCC) was assessed in this research study. The result of this research study is described herein.
MATERIAL AND METHODS: A tertiary hospital-based observational case-control research was carried out. DNA segregation and Genotype examination were done from the blood sample of the control group and cases to know the correlation between XRCC-1 gene polymorphism with loco-regionally progressed LSCC and with hazard factors tobacco and alcohol.
RESULTS: In the cases, the existence of DNA repair XRCC-1 gene polymorphic variants (Hetero CT and Mutant TT) was recognizable in contrary to the control group arm. The XRCC-1 gene polymorphic hetero (CT) genotype (O.R-1.96; 95% C.I: 1.23-3.13; P < 0.004) and mutant (TT) genotype variants (O.R-1.95; 95% C.I: 0.59-6.44; P = 0.27) was correlated with access hazard of loco-regionally progressed LSCC, and its statistically convincing for polymorphic hetero (CT) variant. The data were adapted for the age of the patients and control group, circadian alcohol intake, tobacco chewing habits, and the tobacco smoking habits during application of multivariate logistic regression. Its apparent that the hazard is amalgamated with hetero (CT) genotype variant (O.R- 1.67; 95% C.I: 0.98-2.82; P = 0.05) and mutant (TT) genotype variant (O.R- 1.62; 95% C.I: 0.88-2.78; P = 0.11) and its statistically convincing for polymorphic hetero (CT) genotype variant. Cases with the record of substance use (alcohol and tobacco) have an abundance of XRCC-1 hetero (CT) and mutant (TT) genotype variants in allegory to control group. Increased hazard is related with XRCC-1 hetero (CT) variant in smokers (O.R 3.28; 95% C.I: 1.45-7.41; P = 0.004), in tobacco chewers (O.R-3.79; 95% C.I: 1.87-7.71; P = 0.0002), and in alcohol consumers (O.R- 4.24; 95% C.I: 2.21-8.15; P= <0.0001) which is statistically significant.
CONCLUSION: This research investigation demonstrates the correlation of XRCC-1 polymorphic hetero genotype (CT) & mutant genotype (TT) variants as hazard factor in loco-regionally progressed LSCC. Cases with the record of alcohol intake habits, tobacco smoking and chewing habits and XRCC-1 hetero genotype (CT) variant have statistically increased the hazard of loco-regionally progressed LSCC, which demonstrate the role of gene-ecological interconnection in modifying the vulnerability of loco-regionally progressed LSCC.

Entities:  

Year:  2018        PMID: 30370213      PMCID: PMC6199179          DOI: 10.1016/j.jobcr.2018.10.002

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  15 in total

1.  XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.

Authors:  R M Lunn; R G Langlois; L L Hsieh; C L Thompson; D A Bell
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

2.  X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance.

Authors:  Shin-Young Park; Wing Lam; Yung-chi Cheng
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

3.  Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck.

Authors:  E M Sturgis; E J Castillo; L Li; R Zheng; S A Eicher; G L Clayman; S S Strom; M R Spitz; Q Wei
Journal:  Carcinogenesis       Date:  1999-11       Impact factor: 4.944

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

6.  Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair.

Authors:  Volker Harth; Martin Schafer; Josef Abel; Laura Maintz; Thomas Neuhaus; Mette Besuden; Robert Primke; Anja Wilkesmann; Ricarda Thier; Hans Vetter; Yon-Dschun Ko; Thomas Bruning; Hermann M Bolt; Katja Ickstadt
Journal:  J Toxicol Environ Health A       Date:  2008

7.  Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer.

Authors:  H C Hung; J Chuang; Y C Chien; H D Chern; C P Chiang; Y S Kuo; A Hildesheim; C J Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-11       Impact factor: 4.254

Review 8.  Staging of laryngeal and hypopharyngeal cancer: value of imaging studies.

Authors:  Robert Hermans
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 7.034

9.  ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines.

Authors:  David A Weaver; Erin L Crawford; Kristy A Warner; Fadel Elkhairi; Sadik A Khuder; James C Willey
Journal:  Mol Cancer       Date:  2005-05-09       Impact factor: 27.401

10.  DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.

Authors:  Yin Lou; Wen-jia Peng; Dong-sheng Cao; Juan Xie; Hong-hong Li; Zheng-xuan Jiang
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more
  2 in total

1.  Characterization of long non-coding RNA and messenger RNA profiles in laryngeal cancer by weighted gene co-expression network analysis.

Authors:  Huanhuan Liu; Yi Sun; Huan Tian; Xiaolian Xiao; Jiaqi Zhang; Yongzhen Wang; Fengyan Yu
Journal:  Aging (Albany NY)       Date:  2019-11-18       Impact factor: 5.682

2.  Lung cancer‑associated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR‑493.

Authors:  Zhen Zhao; Yan Xing; Yan Liu; Shanghua Jing
Journal:  Mol Med Rep       Date:  2020-11-20       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.